Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Parathyroid carcinoma is a malignant neoplasm arising from the parathyroid parenchymal cells, comprising approximately 1% of all primary hyperparathyroidism (HPT) cases (no malignant adipose tumors are recognized in the parathyroid). Secondary parathyroid hyperplasia and neck irradiation are suggested as etiologic factors. There is also an increased incidence of carcinoma in patients with hereditary hyperparathyroidism–jaw tumor (HPT-JT) syndrome. There are no well-accepted histologic features that are used alone to diagnose carcinoma, but a constellation of features can help to confirm the diagnosis.
A malignant neoplasm derived from parathyroid parenchymal cells
Accounts for < 2% of primary hyperparathyroidism
Slightly higher frequency in lower parathyroid glands
Adverse effects of hypercalcemia on the cardiovascular system
Indolent tumor with recurrences and metastases, up to 15% mortality at 5 years
Equal sex distribution
Japanese and Italian patients have a higher incidence
Wide age range, although predominantly older patients; still ~10 years younger than patients with adenoma
Symptoms referable to excess calcium and parathyroid hormone
Nephrolithiasis and bone “brown tumors”
Palpable neck mass, often difficult to remove surgically
Hoarseness is common with recurrent laryngeal nerve involvement
May be part of hereditary hyperparathyroidism–jaw tumor syndrome
High serum calcium and parathyroid hormone levels
Indolent with recurrences common (~50%)
Approximately 50% 10-year survival
Surgery
Parathyroid carcinoma affects fewer than 1/1,000,000 population per year, develops in all ages, although more frequently in older adults (mean 6th decade) and up to a decade earlier than adenoma. There is no sex bias, distinctly different from the marked female predominance in patients with parathyroid adenoma. Japanese and Italian patients show a higher incidence of carcinoma than other races.
The clinical features are due primarily to the effects of excessive parathyroid hormone (PTH) secretion and hypercalcemia. Laboratory values of greater than 1,000 ng/L for PTH and greater than 16 mg/dL for serum calcium are very concerning for parathyroid carcinoma. The nonspecific symptoms (weakness, fatigue, anorexia, weight loss, nausea, polyuria, polydipsia) overlap with adenoma, but excessively high serum calcium levels (>16 mg/dL) are associated with nephrolithiasis, renal insufficiency, and bone “brown tumors.” Concurrent bone disease and kidney stones are more common in patients with carcinoma than adenoma. A palpable neck mass (in up to 75% of patients) suggests carcinoma and is often difficult to remove at surgery due to adherence to the soft tissues, nerves (recurrent laryngeal nerve involvement gives hoarseness), and/or thyroid gland. Carcinoma may develop in any parathyroid gland but is slightly more common in the lower parathyroid glands.
Most cases are sporadic, with only a small subset associated with familial disease forms. There are recurrent losses of chromosome 13q, the same region known to contain the retinoblastoma (RB1) and BRCA2 tumor suppressor genes. A genomic region frequently lost in parathyroid adenomas is 11q, the location of MEN1 , but it is almost never identified in carcinoma, supporting the contention that parathyroid carcinomas arise de novo rather than from preexisting adenomas. Carcinoma is a component of HPT-JT syndrome, where it is identified in approximately 15% of patients. Carcinomas are rarely associated with prior irradiation, renal failure, and celiac disease. Radiographic studies are usually unreliable in separating adenoma from carcinoma but can aid in planning surgery.
Large tumors (mean, 3 cm)
Adherent to soft tissues and thyroid gland
Firm, gray-white cut surface
Central necrosis may be present
Adherence to the thyroid gland
Capsular, vascular, or perineural invasion
Soft tissue extension
Tumor cell necrosis (comedonecrosis)
Trabecular growth with thick, acellular bands of fibrosis
Tumor cell monotony, although profound pleomorphism can be seen
High nuclear to cytoplasmic ratio
Spindling of tumor cells
Prominent, eosinophilic, irregular macronucleoli
Increased mitotic figures, including atypical forms
Chromogranin and parathyroid hormone, along with keratins
Loss of parafibromin
Increased Ki-67 labeling index
Cyclin D1 overexpression
Negative TTF1 and thyroglobulin
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here